Evaluation of epidemiological characteristics and risk factors affecting mortality in patients with candidemia

Evaluation of epidemiological characteristics and risk factors affecting mortality in patients with candidemia

Background/aim: The aim of this study was to determine epidemiologic characters of patients with candidemia and to evaluate risk factors that can affect mortality rates among these patients. Materials and methods: Patients admitted to the İstanbul Medeniyet University Göztepe Training Hospital between 2009 and 2011 who had a positive blood culture for Candida spp. during hospitalization were studied retrospectively for demographic characteristics and risk factors. Statistical comparisons were estimated with the Stata 12 package. Independent variables associated with mortality were estimated by Cox regression analyses. Results: A total of 89 patients were identified with a positive blood culture. Of the isolates, 72% (64/89) were C. albicans and 10% (9/89) were non-albicans Candida, while 18% (16/89) were unidentified. C. parapsilosis was the most frequently isolated species among nonalbicans Candida. The crude mortality rate among candidemia cases was 30% (27/89). By univariate analysis, being in the ICU and age (≥50 or ≥60) were found to be statistically significant, whereas by multivariate analysis only age of ≥50 years was independently more associated with mortality (OR, 2.7; CI, 1.05 6.73). Conclusion: Candidemia is associated with high mortality rates. Patients older than 50 years are found to be at considerable risk in terms of adverse outcomes.

___

  • 1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309- 317.
  • 2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163.
  • 3. Edwards JE. Candida species. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA, USA: Churchill Livingstone; 2010. pp. 3225-3240.
  • 4. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS,  Rinaldi MG,  Saiman L,  Wiblin RT et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177- 186.
  • 5. McKinnon PS, Goff DA, Kern JW, Devlin JW, Barletta JF, Sierawski SJ,  Mosenthal AC,  Gore P,  Ambegaonkar AJ, Lubowski TJ. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001; 136: 1401- 1408.
  • 6. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk Factors for hospital-acquired candidemia: a matched casecontrol study. Arch Intern Med 1989; 149: 2349-2353.
  • 7. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 2010; 14: 954-966.
  • 8. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RC, Messer SA. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-3259.
  • 9. Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 2006; 49: 134-138.
  • 10. Gürcüoğlu E, Ener B, Akalin H, Sinirtaş M, Evci C, Akçağlar S, Yilmaz E, Heper Y. Epidemiology of nosocomial candidaemia in a university hospital: a 12-year study. Epidemiol Infect 2010; 138: 1328-1335.
  • 11. Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents 2008; 32: 87-91.
  • 12. Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R,  Pallavicini FB,  Viscoli C. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006; 10: 21-25.
  • 13. Koçak BY, Kuloğlu F, Çelik AD, Akata F. Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital. Mikrobiyol Bul 2011; 45: 489-503 (in Turkish with English abstract).
  • 14. Barberino MG, Silva N, Rebouças C, Barreiro K, Alcântara AP, Netto EM, Albuquerque L, Brites C. Evaluation of blood stream infections by Candida in three tertiary hospitals in Salvador; Brazil: a case-control study. Braz J Infect Dis 2006; 10: 36-40.
  • 15. Chaiwarith R, Ounbang P, Khamwan C, Nuntachit N, Sirisanthana T, Supparatpinyo K. Epidemiology of adult candidemia at Chiang Mai Universty Hospital. Southeast Asian J Trop Med Public Health 2011; 42: 1505-1514.
  • 16. Das I, Nightingale P, Patel M, Jumaa P. Epidemiology, clinical characteristics and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Inf Dis 2011; 15: 759- 763.
  • 17. Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008; 36: 1993-1998.
  • 18. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414-421.
  • 19. Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unitacquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008; 106: 523-529.
  • 20. Chi HW, Yang YS, Shang ST,Chen KH, Yeh KM, Chang FY, Lin JC. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. J Microbiol Immunol Infect 2011; 44: 369-375.
  • 21. Davis SL, Vazquez JA, McKinnon PS. Epidemiology, risk factors and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother 2007; 41: 568-573.
  • 22. Erdem I, Oguzoglu N, Ozturk Engin D, Ozgultekin A, Inan AS, Ceran N, Kaya F, Genc I, Goktas P. Incidence, etiology and risk factors associated with mortality of nosocomial candidemia in a tertiary care hospital in Istanbul, Turkey. Med Princ Pract 2010; 19: 463-467.